Results 1 to 10 of about 69,031,262 (351)

The development of COVID-19 treatment. [PDF]

Front Immunol, 2023
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century.
Yuan Y, Jiao B, Qu L, Yang D, Liu R.
europepmc   +5 more sources

Molnupiravir: A new candidate for COVID‐19 treatment

Pharmacology Research & Perspectives, 2022
The novel coronavirus disease 2019 (COVID‐19) emerged in late December 2019 in china and has rapidly spread to many countries around the world. The effective pharmacotherapy can reduce the mortality of COVID‐19.
Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Haleh Rezaee   +2 more
doaj   +2 more sources

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. [PDF]

Ann Intern Med
Description: In March 2020, the White House Coronavirus Task Force determined that clinicians in the United States needed expert treatment guidelines to optimally manage patients with COVID-19, a potentially life-threatening disease caused by a new ...
Gulick RM, Pau AK, Daar E, Evans L, Gandhi RT, Tebas P, Ridzon R, Masur H, Lane HC, NIH COVID-19 Treatment Guidelines Panel, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio P, Bhalla A, Burgess T, Campbell D, Cantrill S, Chew K, Chiotos K, Coopersmith C, Davey R, Dzierba A, Eisnor D, Eschenauer G, Francis J, Gallagher J, Glidden D, Goldenberg N, Grund B, Han A, Hardy E, Harrison C, Henderson L, Higgs E, Hinkson C, Hughes B, Johnson S, Keller M, Kim A, Knight R, Kuriakose S, Lennox J, Lerner A, Levy M, Li J, MacBrayne C, Martin G, Nadig N, Nason M, Patel P, Pavia A, Proschan M, Schulert G, Seam N, Sheikh V, Simpson S, Singh K, Swindells S, Tien P, Uyeki T, Waghmare A, Wolfe C, Yazdany J, Aberg J.   +65 more
europepmc   +2 more sources

Management of COVID-19: Recommendations of the Third Affiliated Hospital of Sun Yat-sen University （Omicron Edition） [PDF]

Xin yixue, 2023
Although the pathogenicity of SARS-CoV-2 Omicron variant is decreasing, severe and critical cases caused by the virus pose a huge challenge to the medical system due to its strong transmissibility and large population base in China.

doaj   +1 more source

Diagnosis and Treatment Protocol for Special Population Infected with COVID-19 （The Third Affiliated Hospital of Sun Yat-sen University） [PDF]

Xin yixue, 2023
At present， the focus of prevention and control of COVID-19 in China has shifted to prevention and treatment of severe and critically ill cases. Medical staff has constantly adhered to the principle of “People First， Life First” and the people-oriented ...

doaj   +1 more source

Emotional Regulation in Individuals, Standing in Codependent Relationship [PDF]

Клиническая и специальная психология, 2021
The article presents the research of the emotion regulation in women standing in relationships with addicted partners. It also provides additional results of adaptation of the “Spann–Fischer Codependency Scale” (SF CDS). The sample of the study consisted
Berdichevsky A.A., Padun M.A., Gagarina M.A., Arkhipova M.V.   +3 more
doaj   +1 more source

Prevention and Control of COVID-19 after Resuming General Hospital Functions

Pathogens, 2022
During the COVID-19 pandemic, many general hospitals have been transformed into designated infectious disease care facilities, where a large number of patients with COVID-19 infections have been treated and discharged.
Jingwen Li, Hanshu Liu, Chao Duan, Lan Chen, Qing Zhang, Xi Fang, Lei Tan, Na Li, Xinyi Wang, Xing Zhang, Chunmei Li, Zhicheng Lin, Nian Xiong   +12 more
doaj   +1 more source

A Novel Approach for COVID-19 Patient Condition Tracking: From Instant Prediction to Regular Monitoring

Frontiers in Medicine, 2021
Purpose: The aim of this research is to develop an accurate and interpretable aggregated score not only for hospitalization outcome prediction (death/discharge) but also for the daily assessment of the COVID-19 patient's condition.Patients and Methods ...
Evgeny A. Bakin, Evgeny A. Bakin, Oksana V. Stanevich, Oksana V. Stanevich, Mikhail P. Chmelevsky, Mikhail P. Chmelevsky, Vasily A. Belash, Anastasia A. Belash, Galina A. Savateeva, Veronika A. Bokinova, Natalia A. Arsentieva, Ludmila F. Sayenko, Evgeny A. Korobenkov, Dmitry A. Lioznov, Dmitry A. Lioznov, Areg A. Totolian, Yury S. Polushin, Alexander N. Kulikov   +17 more
doaj   +1 more source

Antibiotics for the treatment of COVID‐19

Безопасность и риск фармакотерапии, 2022
This article is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Review previously published in the Cochrane Database of Systematic Reviews.
article Editorial
doaj   +1 more source

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine, 2020
Background Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.
J. Beigel, Kay M. Tomashek, L. Dodd, A. Mehta, Barry S. Zingman, Andre C. Kalil, E. Hohmann, Helen Y. Chu, Anne F Luetkemeyer, S. Kline, Diego López de Castilla, R. Finberg, K. Dierberg, V. Tapson, L. Hsieh, Thomas F. Patterson, R. Paredes, Daniel A. Sweeney, William R. Short, G. Touloumi, D. Lye, N. Ohmagari, M. Oh, G. Ruiz-Palacios, T. Benfield, G. Fätkenheuer, M. Kortepeter, R. Atmar, C. Creech, J. Lundgren, A. Babiker, S. Pett, J. Neaton, T. Burgess, Tyler Bonnett, Michelle Green, M. Makowski, A. Osinusi, S. Nayak, H. Lane   +39 more
semanticscholar   +1 more source